Literature DB >> 27071718

Nucleoporin genes in human diseases.

Valeria Nofrini1, Danika Di Giacomo1, Cristina Mecucci1.   

Abstract

Nuclear pore complexes (NPCs) are large channels spanning the nuclear envelope that mediate nucleocytoplasmic transport. They are composed of multiple copies of ~30 proteins termed nucleoporins (NUPs). Alterations in NUP genes are linked to several human neoplastic and non-neoplastic diseases. This review focuses on NUPs, their genes, localization, function in the NPC and involvement in human diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27071718      PMCID: PMC5027676          DOI: 10.1038/ejhg.2016.25

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  70 in total

1.  NUP98/11p15 translocations affect CD34+ cells in myeloid and T lymphoid leukemias.

Authors:  Barbara Crescenzi; Valeria Nofrini; Gianluca Barba; Caterina Matteucci; Danika Di Giacomo; Paolo Gorello; Berna Beverloo; Antonella Vitale; Iwona Wlodarska; Peter Vandenberghe; Roberta La Starza; Cristina Mecucci
Journal:  Leuk Res       Date:  2015-05-07       Impact factor: 3.156

2.  Nuclear architecture dictates HIV-1 integration site selection.

Authors:  Bruna Marini; Attila Kertesz-Farkas; Hashim Ali; Bojana Lucic; Kamil Lisek; Lara Manganaro; Sandor Pongor; Roberto Luzzati; Alessandra Recchia; Fulvio Mavilio; Mauro Giacca; Marina Lusic
Journal:  Nature       Date:  2015-03-02       Impact factor: 49.962

3.  Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model.

Authors:  Sarah Greenblatt; Li Li; Christopher Slape; Bao Nguyen; Rachel Novak; Amy Duffield; David Huso; Stephen Desiderio; Michael J Borowitz; Peter Aplan; Donald Small
Journal:  Blood       Date:  2012-02-08       Impact factor: 22.113

4.  Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements.

Authors:  M Fornerod; J Boer; S van Baal; M Jaeglé; M von Lindern; K G Murti; D Davis; J Bonten; A Buijs; G Grosveld
Journal:  Oncogene       Date:  1995-05-04       Impact factor: 9.867

5.  Tumor marker nucleoporin 88 kDa regulates nucleocytoplasmic transport of NF-kappaB.

Authors:  Nozomi Takahashi; Jeroen W J van Kilsdonk; Benedikt Ostendorf; Ruben Smeets; Sophia W M Bruggeman; Angel Alonso; Fons van de Loo; Matthias Schneider; Wim B van den Berg; Guido W M Swart
Journal:  Biochem Biophys Res Commun       Date:  2008-07-11       Impact factor: 3.575

6.  Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-HOXD13-driven mouse model.

Authors:  Haiming Xu; Silvia Menendez; Brigitte Schlegelberger; Narae Bae; Peter D Aplan; Gudrun Göhring; Tony R Deblasio; Stephen D Nimer
Journal:  Blood       Date:  2012-08-27       Impact factor: 22.113

7.  Biallelic Mutations in Nuclear Pore Complex Subunit NUP107 Cause Early-Childhood-Onset Steroid-Resistant Nephrotic Syndrome.

Authors:  Noriko Miyake; Hiroyasu Tsukaguchi; Eriko Koshimizu; Akemi Shono; Satoko Matsunaga; Masaaki Shiina; Yasuhiro Mimura; Shintaro Imamura; Tomonori Hirose; Koji Okudela; Kandai Nozu; Yuko Akioka; Motoshi Hattori; Norishige Yoshikawa; Akiko Kitamura; Hae Il Cheong; Shoji Kagami; Michiaki Yamashita; Atsushi Fujita; Satoko Miyatake; Yoshinori Tsurusaki; Mitsuko Nakashima; Hirotomo Saitsu; Kenichi Ohashi; Naoko Imamoto; Akihide Ryo; Kazuhiro Ogata; Kazumoto Iijima; Naomichi Matsumoto
Journal:  Am J Hum Genet       Date:  2015-09-24       Impact factor: 11.025

8.  Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2.

Authors:  Derek E Neilson; Mark D Adams; Caitlin M D Orr; Deborah K Schelling; Robert M Eiben; Douglas S Kerr; Jane Anderson; Alexander G Bassuk; Ann M Bye; Anne-Marie Childs; Antonia Clarke; Yanick J Crow; Maja Di Rocco; Christian Dohna-Schwake; Gregor Dueckers; Alfonso E Fasano; Artemis D Gika; Dimitris Gionnis; Mark P Gorman; Padraic J Grattan-Smith; Annette Hackenberg; Alice Kuster; Markus G Lentschig; Eduardo Lopez-Laso; Elysa J Marco; Sotiria Mastroyianni; Julie Perrier; Thomas Schmitt-Mechelke; Serenella Servidei; Angeliki Skardoutsou; Peter Uldall; Marjo S van der Knaap; Karrie C Goglin; David L Tefft; Cristin Aubin; Philip de Jager; David Hafler; Matthew L Warman
Journal:  Am J Hum Genet       Date:  2009-01       Impact factor: 11.025

9.  Modulation of chromatin position and gene expression by HDAC4 interaction with nucleoporins.

Authors:  Izhak Kehat; Federica Accornero; Bruce J Aronow; Jeffery D Molkentin
Journal:  J Cell Biol       Date:  2011-04-04       Impact factor: 10.539

Review 10.  Nuclear pore proteins and the control of genome functions.

Authors:  Arkaitz Ibarra; Martin W Hetzer
Journal:  Genes Dev       Date:  2015-02-15       Impact factor: 11.361

View more
  41 in total

1.  Biallelic Variants in the Nuclear Pore Complex Protein NUP93 Are Associated with Non-progressive Congenital Ataxia.

Authors:  Ginevra Zanni; P De Magistris; M Nardella; E Bellacchio; S Barresi; A Sferra; A Ciolfi; M Motta; H Lue; D Moreno-Andres; M Tartaglia; E Bertini; Wolfram Antonin
Journal:  Cerebellum       Date:  2019-06       Impact factor: 3.847

Review 2.  Causes and consequences of nuclear gene positioning.

Authors:  Sigal Shachar; Tom Misteli
Journal:  J Cell Sci       Date:  2017-04-12       Impact factor: 5.285

Review 3.  The roles of the nuclear pore complex in cellular dysfunction, aging and disease.

Authors:  Stephen Sakuma; Maximiliano A D'Angelo
Journal:  Semin Cell Dev Biol       Date:  2017-05-12       Impact factor: 7.727

4.  Mutated NUP188 and Other Nucleoporins as Gateways to Developmental Syndromes.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2020-02-15

5.  Integrative structure and functional anatomy of a nuclear pore complex.

Authors:  Seung Joong Kim; Javier Fernandez-Martinez; Ilona Nudelman; Yi Shi; Wenzhu Zhang; Barak Raveh; Thurston Herricks; Brian D Slaughter; Joanna A Hogan; Paula Upla; Ilan E Chemmama; Riccardo Pellarin; Ignacia Echeverria; Manjunatha Shivaraju; Azraa S Chaudhury; Junjie Wang; Rosemary Williams; Jay R Unruh; Charles H Greenberg; Erica Y Jacobs; Zhiheng Yu; M Jason de la Cruz; Roxana Mironska; David L Stokes; John D Aitchison; Martin F Jarrold; Jennifer L Gerton; Steven J Ludtke; Christopher W Akey; Brian T Chait; Andrej Sali; Michael P Rout
Journal:  Nature       Date:  2018-03-14       Impact factor: 49.962

6.  Molecular assay for an intronic variant in NUP93 that causes steroid resistant nephrotic syndrome.

Authors:  Rini Rossanti; Akemi Shono; Kenichiro Miura; Motoshi Hattori; Tomohiko Yamamura; Keita Nakanishi; Shogo Minamikawa; Junya Fujimura; Tomoko Horinouchi; China Nagano; Nana Sakakibara; Hiroshi Kaito; Hiroaki Nagase; Naoya Morisada; Katsuhiko Asanuma; Masafumi Matsuo; Kandai Nozu; Kazumoto Iijima
Journal:  J Hum Genet       Date:  2019-04-23       Impact factor: 3.172

Review 7.  Nuclear pore complexes - a doorway to neural injury in neurodegeneration.

Authors:  Alyssa N Coyne; Jeffrey D Rothstein
Journal:  Nat Rev Neurol       Date:  2022-04-29       Impact factor: 42.937

8.  Linking Nucleoporins, Mitosis, and Colon Cancer.

Authors:  Richard W Wong; Maximiliano D'Angelo
Journal:  Cell Chem Biol       Date:  2016-05-19       Impact factor: 8.116

Review 9.  Oncogenic potential of nucleoporins in non-hematological cancers: recent update beyond chromosome translocation and gene fusion.

Authors:  Adhiraj Roy; Gopeshwar Narayan
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-25       Impact factor: 4.553

10.  Obesity-associated gene TMEM18 has a role in the central control of appetite and body weight regulation.

Authors:  Rachel Larder; M F Michelle Sim; Pawan Gulati; Robin Antrobus; Y C Loraine Tung; Debra Rimmington; Eduard Ayuso; Joseph Polex-Wolf; Brian Y H Lam; Cristina Dias; Darren W Logan; Sam Virtue; Fatima Bosch; Giles S H Yeo; Vladimir Saudek; Stephen O'Rahilly; Anthony P Coll
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.